Machine learning helps to predict the treatment outcomes of schizophrenia
U of A research building better tools for diagnosis and treatment of mental health disorders.
U of A research building better tools for diagnosis and treatment of mental health disorders.
Cognitive deficits can be functionally debilitating and are common features of many neuropsychiatric disorders.
Neurocognitive deficits are frequently observed in patients with schizophrenia and major depressive disorder (MDD).
Mood disorders and neurocognitive impairments are debilitating conditions among patients with HIV/AIDS.
To assess the relationship between the Screen for Cognitive Impairment in Psychiatry (SCIP) score and illness severity, subjective cognition and functioning in a cohort of major depressive disorder (MDD) patients
Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is made from bark of the Banisteriopsis caapi vine (contains beta-carboline alkaloids) and leaves of the Psychotria viridis bush (supply the hallucinogen N,N-dimethyltryptamine (DMT)). Originally used by indigenous shamans for the purposes of spirit communication, magical experiences, healing, and religious rituals, across several South American countries ayahuasca has been incorporated into folk medicine and spiritual healing, and several Brazilian churches use it routinely to foster spiritual experience.
Fetal Alcohol Spectrum Disorder (FASD) is a preventable disorder caused by maternal alcohol consumption and marked by a range of physical and mental disabilities. Although recognized by the scientific and medical community as a clinical disorder, no internationally standardized diagnostic tool yet exists for FASD
The Canadian Psychiatric Association (CPA) is the national leading authority on psychiatric matters in Canada with a stated vision of a strong profession for a healthy population.